应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09997 康基医疗
停牌 03-25 16:00:00
9.200
+0.000
0.00%
最高
9.200
最低
9.200
成交量
0.00
今开
9.200
昨收
9.200
日振幅
0.00%
总市值
111.14亿
流通市值
111.14亿
总股本
12.08亿
成交额
0.00
换手率
0.00%
流通股本
12.08亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
新产业(300832)披露获得医疗器械注册证公告,3月25日股价下跌0.24%
证券之星 · 03-25 22:20
新产业(300832)披露获得医疗器械注册证公告,3月25日股价下跌0.24%
泰凌医药(01011)完成收购浙江康源医疗器械58.11%股权
智通财经 · 03-25 19:21
泰凌医药(01011)完成收购浙江康源医疗器械58.11%股权
新产业最新公告:获得超氧化物歧化酶测定试剂盒医疗器械注册证
证券之星 · 03-25 18:20
新产业最新公告:获得超氧化物歧化酶测定试剂盒医疗器械注册证
赛克赛斯科创板IPO获受理 专注于体内可吸收植介入医疗器械赛道
智通财经网 · 03-24 18:48
赛克赛斯科创板IPO获受理 专注于体内可吸收植介入医疗器械赛道
九州通最新公告:控股子公司取得经颅重复磁刺激仪医疗器械注册证
证券之星 · 03-24 17:39
九州通最新公告:控股子公司取得经颅重复磁刺激仪医疗器械注册证
普门科技(688389.SH)取得一项医疗器械注册证
智通财经 · 03-24 15:51
普门科技(688389.SH)取得一项医疗器械注册证
科华生物(002022)披露控股子公司实时荧光定量PCR仪获医疗器械注册证,3月23日股价下跌5.74%
证券之星 · 03-23 22:45
科华生物(002022)披露控股子公司实时荧光定量PCR仪获医疗器械注册证,3月23日股价下跌5.74%
科华生物(002022.SZ)子公司取得一项医疗器械注册证
智通财经 · 03-23 17:08
科华生物(002022.SZ)子公司取得一项医疗器械注册证
德适-B,流通股最少84亿,专注于医学影像AI产品及医疗器械——(02526.HK)2026年3月新股分析 原创 机构喵 机构喵 爱打新的猫 202
爱投资的小熊猫 · 03-22
德适-B,流通股最少84亿,专注于医学影像AI产品及医疗器械——(02526.HK)2026年3月新股分析 原创 机构喵 机构喵 爱打新的猫 202
三诺生物(300298)披露取得七项医疗器械注册证公告,3月20日股价下跌2.05%
证券之星 · 03-20
三诺生物(300298)披露取得七项医疗器械注册证公告,3月20日股价下跌2.05%
美丽田园医疗健康(02373):奈瑞儿医疗器械认购总金额为5000万元的保本理财产品
智通财经 · 03-20
美丽田园医疗健康(02373):奈瑞儿医疗器械认购总金额为5000万元的保本理财产品
新产业(300832)披露获得医疗器械注册证的公告,3月20日股价下跌0.32%
证券之星 · 03-20
新产业(300832)披露获得医疗器械注册证的公告,3月20日股价下跌0.32%
昌红科技:获得某全球头部医疗器械企业介入类微创手术耗材模具订单
证券之星 · 03-20
昌红科技:获得某全球头部医疗器械企业介入类微创手术耗材模具订单
之江生物(688317)披露公司产品获得马来西亚医疗器械管理局认证,3月19日股价下跌2.06%
证券之星 · 03-19
之江生物(688317)披露公司产品获得马来西亚医疗器械管理局认证,3月19日股价下跌2.06%
浩欧博(688656)披露全资子公司获得两项医疗器械注册证,3月18日股价上涨0.69%
证券之星 · 03-18
浩欧博(688656)披露全资子公司获得两项医疗器械注册证,3月18日股价上涨0.69%
博济医药:服务植入式脑深部刺激系统等脑科医疗器械
证券之星 · 03-18
博济医药:服务植入式脑深部刺激系统等脑科医疗器械
微创脑科学(02172):APOLLO Dream®雷帕霉素靶向洗脱支架系统荣获FDA突破性医疗器械认定
智通财经 · 03-18
微创脑科学(02172):APOLLO Dream®雷帕霉素靶向洗脱支架系统荣获FDA突破性医疗器械认定
浩欧博(688656.SH)子公司获得2项医疗器械注册证
智通财经网 · 03-18
浩欧博(688656.SH)子公司获得2项医疗器械注册证
万东医疗(600055.SH):“磁共振成像系统”取得医疗器械注册证
智通财经 · 03-17
万东医疗(600055.SH):“磁共振成像系统”取得医疗器械注册证
贝康医疗-B(02170):PGT-A试剂盒获国家药监局颁发医疗器械注册证
智通财经 · 03-16
贝康医疗-B(02170):PGT-A试剂盒获国家药监局颁发医疗器械注册证
加载更多
公司概况
公司名称:
康基医疗
所属市场:
SEHK
上市日期:
--
主营业务:
康基医疗控股有限公司是一家主要从事微创外科手术器械及配件的设计、开发、制造及销售业务的投资控股公司。该公司的一次性产品包括一次性套管穿刺器、高分子结扎夹、一次性电凝钳、超声切割止血刀及其他一次性产品。重复性产品包括4K内窥镜摄像系统和其他重复性产品。该公司的产品应用于妇产科、泌尿外科、普通外科和胸外科等领域。该公司还提供投资咨询服务。该公司产品销往国内市场及海外市场。
发行价格:
--
{"stockData":{"symbol":"09997","market":"HK","secType":"STK","nameCN":"康基医疗","latestPrice":9.2,"timestamp":1774425600000,"preClose":9.2,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":1208000000,"shares":1208000000,"eps":0.494525,"marketStatus":"停牌","change":0,"latestTime":"03-25 16:00:00","open":9.2,"high":9.2,"low":9.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.51,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774488600000},"marketStatusCode":0,"adr":0,"listingDate":1593360000000,"exchange":"SEHK","adjPreClose":9.2,"dividendRate":0.029743,"openAndCloseTimeList":[[1774402200000,1774411200000],[1774414800000,1774425600000]],"volumeRatio":2.7223492263848823,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09997","defaultTab":"news","newsList":[{"id":"2622072606","title":"新产业(300832)披露获得医疗器械注册证公告,3月25日股价下跌0.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622072606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622072606?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:20","pubTimestamp":1774448434,"startTime":"0","endTime":"0","summary":"截至2026年3月25日收盘,新产业报收于49.88元,较前一交易日下跌0.24%,最新总市值为391.92亿元。该股当日开盘49.88元,最高50.09元,最低49.37元,成交额达1.31亿元,换手率为0.39%。公司于近日收到广东省药品监督管理局颁发的1项《医疗器械注册证》,产品为超氧化物歧化酶测定试剂盒,属于Ⅱ类医疗器械,注册证有效期为2026年3月24日至2031年3月23日,适用于体外定量测定人血清或血浆中的超氧化物歧化酶活性,临床用于机体抗氧化能力的辅助诊断。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500043944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","300832","09997","09996","BK1574","BK1222","BK1583","BK1100","BK0239"],"gpt_icon":0},{"id":"2622002020","title":"泰凌医药(01011)完成收购浙江康源医疗器械58.11%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2622002020","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622002020?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:21","pubTimestamp":1774437695,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰凌医药 发布公告,就有关公司拟约1.16亿元收购浙江康源医疗器械58.11%股权的相关事宜。公司已于2026年3月25日按每股代价股份0.45港元的发行价向8名卖方发行及配发2.75亿股新股份以完成支付代价,通函“先决条件”分节所载买卖协议及补充协议的所有先决条件已获达成。收购事项完成后,公司透过全资附属公司间接持有浙江康源医疗器械有限公司58.11%股权,其财务业绩将于集团账目内综合入账。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418900.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1100","01011","09996","BK1574","09997","BK1222","BK1583","BK1191"],"gpt_icon":0},{"id":"2622506022","title":"新产业最新公告:获得超氧化物歧化酶测定试剂盒医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2622506022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622506022?lang=zh_cn&edition=full","pubTime":"2026-03-25 18:20","pubTimestamp":1774434021,"startTime":"0","endTime":"0","summary":"新产业(300832.SZ)公告称,公司近日收到广东省药监局颁发的1项Ⅱ类《医疗器械注册证》,产品为超氧化物歧化酶测定试剂盒(邻苯三酚底物法),有效期至2031年3月23日,用于体外定量测定人血清或血浆中超氧化物歧化酶活性,临床上辅助诊断机体抗氧化能力。该产品丰富了公司生化检测“肾功能”项目类别,对公司发展具有正面影响,但对近期生产经营和业绩无重大影响。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500035895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","09997","BK1574","BK1583","BK1100","BK1222","300832","159883","BK0239"],"gpt_icon":0},{"id":"2621066933","title":"赛克赛斯科创板IPO获受理 专注于体内可吸收植介入医疗器械赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066933","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621066933?lang=zh_cn&edition=full","pubTime":"2026-03-24 18:48","pubTimestamp":1774349332,"startTime":"0","endTime":"0","summary":"3月24日,赛克赛斯生物科技股份有限公司上交所科创板IPO已受理,拟募资6.35亿元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260324/20260324184134_36345.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260324/20260324184134_36345.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418127.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["09997","BK1574","159883","BK1222","BK1583","159982","09996","BK1100"],"gpt_icon":0},{"id":"2621068031","title":"九州通最新公告:控股子公司取得经颅重复磁刺激仪医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2621068031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621068031?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:39","pubTimestamp":1774345190,"startTime":"0","endTime":"0","summary":"九州通(600998.SH)公告称,公司控股子公司武汉柯尼兹医疗科技有限公司近日获得湖北省药监局核准签发的“经颅重复磁刺激仪”医疗器械注册证(编号:鄂械注准20262096046),有效期至2031年3月17日,适用于3岁以上儿童及成人缺血性脑血管病、脑损伤性疾病的辅助治疗。该产品注册证的取得有助于丰富公司医疗器械产品线,推动“新产品”战略落地,但实际销售受行业政策、市场需求等因素影响,未来业绩贡献存在不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400030077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0188","09997","159883","BK0028","BK0250","BK0183","600998","BK0201","09996","BK1583","BK0187","BK0097","BK1574","BK1100","BK0196","BK0039","BK0077","BK0012","BK1222"],"gpt_icon":0},{"id":"2621546190","title":"普门科技(688389.SH)取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2621546190","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621546190?lang=zh_cn&edition=full","pubTime":"2026-03-24 15:51","pubTimestamp":1774338692,"startTime":"0","endTime":"0","summary":"智通财经APP讯,普门科技(688389.SH)公告,公司近期收到了1个广东省药品监督管理局颁发的《医疗器械注册证》,产品名称为:全自动特定蛋白分析仪。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK0251","688389","BK1100","BK1574","BK1583","159883","09996","BK1222"],"gpt_icon":0},{"id":"2621707854","title":"科华生物(002022)披露控股子公司实时荧光定量PCR仪获医疗器械注册证,3月23日股价下跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621707854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621707854?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:45","pubTimestamp":1774277119,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,科华生物报收于5.42元,较前一交易日下跌5.74%,最新总市值为27.88亿元。该股当日开盘5.65元,最高5.71元,最低5.37元,成交额达5982.56万元,换手率为2.09%。近日,上海科华生物工程股份有限公司控股子公司西安天隆科技有限公司收到国家药品监督管理局颁发的医疗器械注册证,产品名称为实时荧光定量PCR仪,注册证编号国械注准20263220324,有效期至2031年2月11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300040127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","159883","09997","BK1222","BK0028","BK0188","002022","BK1100","BK0046","09996","BK1574","BK0239"],"gpt_icon":0},{"id":"2621779991","title":"科华生物(002022.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2621779991","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621779991?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:08","pubTimestamp":1774256908,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科华生物(002022.SZ)公告,公司控股子公司西安天隆科技有限公司收到国家药品监督管理局颁发的医疗器械注册证,产品名称为:实时荧光定量PCR仪。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK1222","159883","BK1583","002022","09997","BK0028","BK1574","09996","BK1100","BK0239","BK0188"],"gpt_icon":0},{"id":"2621710180","title":"德适-B,流通股最少84亿,专注于医学影像AI产品及医疗器械——(02526.HK)2026年3月新股分析 原创 机构喵 机构喵 爱打新的猫 202","url":"https://stock-news.laohu8.com/highlight/detail?id=2621710180","media":"爱投资的小熊猫","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621710180?lang=zh_cn&edition=full","pubTime":"2026-03-22 22:14","pubTimestamp":1774188840,"startTime":"0","endTime":"0","summary":"上面发文章的这个微信公众号,主要是我们做机构业务为主的,更多的会以机构的视角来看待问题。所以大家也可以多看看,后续应该很多文章会在这里发。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-03-22/doc-inhrwpyr4762705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09996","09997","BK1222","159883","02251","BK1583","BK1100","BK1574","BK1189","02526"],"gpt_icon":0},{"id":"2620173218","title":"三诺生物(300298)披露取得七项医疗器械注册证公告,3月20日股价下跌2.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620173218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620173218?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:30","pubTimestamp":1774017059,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,三诺生物报收于16.22元,较前一交易日下跌2.05%,最新总市值为90.88亿元。该股当日开盘16.61元,最高16.64元,最低16.22元,成交额达6428.06万元,换手率为0.87%。三诺生物传感股份有限公司近日收到湖南省药品监督管理局颁发的七项《医疗器械注册证》。其中,前六项为新获批的II类医疗器械注册证,产品包括血糖试条、血糖尿酸测试条和乳酸试条;第七项为糖尿病管理系统软件的延续注册。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000043761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK1100","BK0251","159883","09996","BK1583","BK0102","BK0114","BK1222","BK1574","09997"],"gpt_icon":0},{"id":"2620387977","title":"美丽田园医疗健康(02373):奈瑞儿医疗器械认购总金额为5000万元的保本理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2620387977","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620387977?lang=zh_cn&edition=full","pubTime":"2026-03-20 19:40","pubTimestamp":1774006813,"startTime":"0","endTime":"0","summary":"智通财经APP讯,美丽田园医疗健康(02373)发布公告,于2026年3月20日,为有效利用闲置资金,奈瑞儿医疗器械根据3月20日认购自浦发银行认购总金额为人民币5000万元的保本理财产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","09996","159883","BK1574","BK1215","BK1100","09997","02373","BK1222"],"gpt_icon":0},{"id":"2620849077","title":"新产业(300832)披露获得医疗器械注册证的公告,3月20日股价下跌0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620849077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620849077?lang=zh_cn&edition=full","pubTime":"2026-03-20 17:34","pubTimestamp":1773999284,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,新产业报收于49.86元,较前一交易日下跌0.32%,最新总市值为391.76亿元。该股当日开盘50.02元,最高50.49元,最低49.31元,成交额达2.27亿元,换手率为0.67%。公司近日收到广东省药品监督管理局颁发的1项《医疗器械注册证》,产品为可溶性生长刺激表达基因2蛋白测定试剂盒,注册证编号粤械注准20262400300,有效期至2031年3月17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000030747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1100","BK0239","300832","BK1222","BK1583","09997","159883","BK1574"],"gpt_icon":0},{"id":"2620786121","title":"昌红科技:获得某全球头部医疗器械企业介入类微创手术耗材模具订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2620786121","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620786121?lang=zh_cn&edition=full","pubTime":"2026-03-20 16:24","pubTimestamp":1773995046,"startTime":"0","endTime":"0","summary":"证券之星消息,昌红科技03月20日在投资者关系平台上答复投资者关心的问题。近日,公司获得某全球头部医疗器械企业的介入类微创手术耗材模具订单,标志着公司在高端医疗器械及耗材精密制造领域取得阶段性突破。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000027713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1574","09996","300151","BK1583","BK0251","159883","BK1100","BK1222"],"gpt_icon":0},{"id":"2620243092","title":"之江生物(688317)披露公司产品获得马来西亚医疗器械管理局认证,3月19日股价下跌2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620243092","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620243092?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:10","pubTimestamp":1773911417,"startTime":"0","endTime":"0","summary":"截至2026年3月19日收盘,之江生物报收于19.47元,较前一交易日下跌2.06%,最新总市值为37.41亿元。近日,上海之江生物科技股份有限公司发布《关于自愿披露公司产品获得相关认证的公告》。公告显示,公司两项产品“Viral RNA Isolation Kit ”和“Viral RNA Extraction Kit”近期获得马来西亚医疗器械管理局认证,认证有效期分别为2026年3月6日至2031年3月5日、2026年2月27日至2031年2月26日,适用范围为临床样本中核酸的提取,可在马来西亚及认可该认证的国家销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900027622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688317","BK1100","09996","BK1222","BK1583","BK0239","09997","159883","BK1574"],"gpt_icon":0},{"id":"2620126252","title":"浩欧博(688656)披露全资子公司获得两项医疗器械注册证,3月18日股价上涨0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620126252","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620126252?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:32","pubTimestamp":1773844336,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘,浩欧博报收于142.03元,较前一交易日上涨0.69%,最新总市值为90.16亿元。该股当日开盘144.0元,最高144.34元,最低137.49元,成交额达5652.8万元,换手率为0.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800040822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","159883","688656","BK1222","BK1583","09996","BK0239","BK1574","BK1100"],"gpt_icon":0},{"id":"2620565256","title":"博济医药:服务植入式脑深部刺激系统等脑科医疗器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2620565256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620565256?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:51","pubTimestamp":1773838302,"startTime":"0","endTime":"0","summary":"有媒体报道贵公司子公司九泰药械目前有为诸如植入式脑深部刺激系统、磁刺激调控治疗抑郁症等脑神经科学方面的医疗器械提供临床研究服务,消息是否属实。九泰药械持续关注国家政策及行业动向带来的行业机遇,提升竞争优势,并专注于为所在领域企业提供优质的医疗器械临床试验及注册申报服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800038770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1583","159883","LU0329678337.USD","09996","BK1209","LU0329678170.USD","LU0737861772.HKD","BK1574","300404","BK1222","LU2488822045.USD","BK0216","BK1100","06078"],"gpt_icon":0},{"id":"2620518239","title":"微创脑科学(02172):APOLLO Dream®雷帕霉素靶向洗脱支架系统荣获FDA突破性医疗器械认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2620518239","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620518239?lang=zh_cn&edition=full","pubTime":"2026-03-18 17:20","pubTimestamp":1773825636,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微创脑科学 发布公告,集团自主研发的APOLLO Dream雷帕霉素靶向洗脱支架系统近期获得美国食品药品监督管理局授予的突破性医疗器械认定,成为全球首个获得该项认定的神经介入领域球囊扩张、快速交换式药物洗脱支架。APOLLO Dream支架系统专为对现有最佳药物治疗无效的症状性颅内动脉狭窄患者而设计。与传统药物支架相比,APOLLO Dream支架系统能够更加精准地控制药物释放剂量,在保证疗效的同时显著降低进入人体的总药物负荷。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1574","BK4585","09996","BK4588","BK1222","BK1583","LABU","02172","09997","159883"],"gpt_icon":0},{"id":"2620690233","title":"浩欧博(688656.SH)子公司获得2项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2620690233","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620690233?lang=zh_cn&edition=full","pubTime":"2026-03-18 16:03","pubTimestamp":1773821033,"startTime":"0","endTime":"0","summary":"浩欧博(688656.SH)发布公告,公司全资子公司湖南浩欧博生物医药有限公司于近日获得2项由湖南省药品监督管理局核准签发的医疗器械注册证,涉及产品:“抗丙氨酰tRNA合成酶(PL-12)抗体检测试剂盒(磁微粒化学发光法)”、“抗苏氨酰tRNA合成酶(PL-7)抗体检测试剂盒(磁微粒化学发光法)”。","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/2.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/2.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","BK1222","09996","159883","BK1583","688656","BK1100","09997","BK0239"],"gpt_icon":0},{"id":"2620441471","title":"万东医疗(600055.SH):“磁共振成像系统”取得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2620441471","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620441471?lang=zh_cn&edition=full","pubTime":"2026-03-17 15:49","pubTimestamp":1773733771,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万东医疗(600055.SH)发布公告,公司于近日收到国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》,涉及产品:“磁共振成像系统”。上述注册证的取得,有助于进一步丰富公司产品结构,不断满足市场需求,有利于进一步增强公司的核心竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK1100","BK1574","09996","600055","BK0070","BK1222","BK0146","BK1583","BK0114","159883","09997"],"gpt_icon":0},{"id":"2619045006","title":"贝康医疗-B(02170):PGT-A试剂盒获国家药监局颁发医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2619045006","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619045006?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:05","pubTimestamp":1773662722,"startTime":"0","endTime":"0","summary":"智通财经APP讯,贝康医疗-B 公布,公司基于国产高通量基因测序平台的 PGT-A试剂盒,胚胎植入前染色体非整倍体检测试剂盒,于2026年3月13日成功获批国家三类医疗器械注册证,成为全国首个基于纯国产自主平台测序仪的PGT-A试剂盒。PGT-A试剂盒透过筛检胚胎染色体非整倍体异常,能有效降低流产风险和出生缺陷发生率,是第三代试管婴儿技术的关键支撑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","02170","BK1583","BK1222","BK1597","BK1574","159883","09996","BK1100"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hzkangji.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0395},{"period":"1year","weight":0.2711},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0265},{"period":"1month","weight":-0.0645},{"period":"3month","weight":-0.0187},{"period":"6month","weight":-0.0303},{"period":"1year","weight":0.0853},{"period":"ytd","weight":-0.0115}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康基医疗控股有限公司是一家主要从事微创外科手术器械及配件的设计、开发、制造及销售业务的投资控股公司。该公司的一次性产品包括一次性套管穿刺器、高分子结扎夹、一次性电凝钳、超声切割止血刀及其他一次性产品。重复性产品包括4K内窥镜摄像系统和其他重复性产品。该公司的产品应用于妇产科、泌尿外科、普通外科和胸外科等领域。该公司还提供投资咨询服务。该公司产品销往国内市场及海外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.033993},{"month":2,"riseRate":0.6,"avgChangeRate":0.022159},{"month":3,"riseRate":0.4,"avgChangeRate":-0.018922},{"month":4,"riseRate":0.8,"avgChangeRate":0.100121},{"month":5,"riseRate":0.6,"avgChangeRate":0.009096},{"month":6,"riseRate":0.2,"avgChangeRate":-0.008486},{"month":7,"riseRate":0.5,"avgChangeRate":-0.023464},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.060866},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.058003},{"month":10,"riseRate":0.5,"avgChangeRate":0.001037},{"month":11,"riseRate":0.666667,"avgChangeRate":0.032731},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.02268}],"exchange":"SEHK","name":"康基医疗","nameEN":"KANGJI MEDICAL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康基医疗(09997)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康基医疗(09997)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康基医疗,09997,康基医疗股票,康基医疗股票老虎,康基医疗股票老虎国际,康基医疗行情,康基医疗股票行情,康基医疗股价,康基医疗股市,康基医疗股票价格,康基医疗股票交易,康基医疗股票购买,康基医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康基医疗(09997)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康基医疗(09997)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}